Early Thrombotic Microangiopathy After ABO-Incompatible Living Donor Kidney Transplantation

Introduction: Although long-term graft survival is comparable with that of ABO-compatible (ABOc) renal transplantation, the risk of antibody-mediated rejection (ABMR) following ABO-incompatible (ABOi) transplantation is higher and can occur as an early thrombotic microangiopathy (TMA). Methods: We d...

Full description

Bibliographic Details

Published in:	Kidney International Reports
Main Authors:	Dominique Bertrand, Arnaud Del Bello, Rebecca Sberro Soussan, Sophie Caillard, Guillaume Claisse, Lionel Couzi, Sophie Girerd, Alexandre Hertig, Yannick Le Meur, Vincent Pernin, Coralie Poulain, Cédric Rafat, Marie Matignon, Arnaud Buteux, Arnaud François, Mathilde Lemoine, Charlotte Laurent, Nassim Kamar, Tristan de Nattes, Dominique Guerrot
Format:	Article
Language:	English
Published:	Elsevier 2025-03-01
Subjects:	ABO-incompatible antibody-mediated rejection eculizumab kidney transplantation thrombotic microangiopathy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924034776